Literature DB >> 11462174

Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36.

C M van Duijn1, M C Dekker, V Bonifati, R J Galjaard, J J Houwing-Duistermaat, P J Snijders, L Testers, G J Breedveld, M Horstink, L A Sandkuijl, J C van Swieten, B A Oostra, P Heutink.   

Abstract

Although the role of genetic factors in the origin of Parkinson disease has long been disputed, several genes involved in autosomal dominant and recessive forms of the disease have been localized. Mutations associated with early-onset autosomal recessive parkinsonism have been identified in the Parkin gene, and recently a second gene, PARK6, involved in early-onset recessive parkinsonism was localized on chromosome 1p35-36. We identified a family segregating early-onset parkinsonism with multiple consanguinity loops in a genetically isolated population. Homozygosity mapping resulted in significant evidence for linkage on chromosome 1p36. Multipoint linkage analysis using MAPMAKER-HOMOZ generated a maximum LOD-score of 4.3, with nine markers spanning a disease haplotype of 16 cM. On the basis of several recombination events, the region defining the disease haplotype can be clearly separated, by > or =25 cM, from the more centromeric PARK6 locus on chromosome 1p35-36. Therefore, we conclude that we have identified on chromosome 1 a second locus, PARK7, involved in autosomal recessive, early-onset parkinsonism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11462174      PMCID: PMC1235491          DOI: 10.1086/322996

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  15 in total

1.  Association between early-onset Parkinson's disease and mutations in the parkin gene.

Authors:  C B Lücking; A Dürr; V Bonifati; J Vaughan; G De Michele; T Gasser; B S Harhangi; G Meco; P Denèfle; N W Wood; Y Agid; A Brice
Journal:  N Engl J Med       Date:  2000-05-25       Impact factor: 91.245

2.  Pitfalls in homozygosity mapping.

Authors:  M G Miano; S G Jacobson; A Carothers; I Hanson; P Teague; J Lovell; A V Cideciyan; N Haider; E M Stone; V C Sheffield; A F Wright
Journal:  Am J Hum Genet       Date:  2000-09-27       Impact factor: 11.025

3.  Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations?

Authors:  J Tassin; A Dürr; A M Bonnet; R Gil; M Vidailhet; C B Lücking; J Y Goas; F Durif; M Abada; B Echenne; J Motte; A Lagueny; L Lacomblez; P Jedynak; B Bartholomé; Y Agid; A Brice
Journal:  Brain       Date:  2000-06       Impact factor: 13.501

4.  The ubiquitin pathway in Parkinson's disease.

Authors:  E Leroy; R Boyer; G Auburger; B Leube; G Ulm; E Mezey; G Harta; M J Brownstein; S Jonnalagada; T Chernova; A Dehejia; C Lavedan; T Gasser; P J Steinbach; K D Wilkinson; M H Polymeropoulos
Journal:  Nature       Date:  1998-10-01       Impact factor: 49.962

5.  A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor.

Authors:  M Farrer; K Gwinn-Hardy; M Muenter; F W DeVrieze; R Crook; J Perez-Tur; S Lincoln; D Maraganore; C Adler; S Newman; K MacElwee; P McCarthy; C Miller; C Waters; J Hardy
Journal:  Hum Mol Genet       Date:  1999-01       Impact factor: 6.150

6.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

7.  Rapid multipoint linkage analysis of recessive traits in nuclear families, including homozygosity mapping.

Authors:  L Kruglyak; M J Daly; E S Lander
Journal:  Am J Hum Genet       Date:  1995-02       Impact factor: 11.025

8.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

9.  Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children.

Authors:  E S Lander; D Botstein
Journal:  Science       Date:  1987-06-19       Impact factor: 47.728

10.  Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36.

Authors:  E M Valente; A R Bentivoglio; P H Dixon; A Ferraris; T Ialongo; M Frontali; A Albanese; N W Wood
Journal:  Am J Hum Genet       Date:  2001-03-07       Impact factor: 11.025

View more
  95 in total

Review 1.  Rare genetic mutations shed light on the pathogenesis of Parkinson disease.

Authors:  Ted M Dawson; Valina L Dawson
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 2.  Current concepts in the diagnosis and management of Parkinson's disease.

Authors:  Mark Guttman; Stephen J Kish; Yoshiaki Furukawa
Journal:  CMAJ       Date:  2003-02-04       Impact factor: 8.262

Review 3.  The genetic basis of Parkinson's disease.

Authors:  T Foltynie; S Sawcer; C Brayne; R A Barker
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-10       Impact factor: 10.154

Review 4.  Genetically engineered mouse models of Parkinson's disease.

Authors:  Donna M Crabtree; Jianhua Zhang
Journal:  Brain Res Bull       Date:  2011-08-03       Impact factor: 4.077

5.  Genome-wide scan linkage analysis for Parkinson's disease: the European genetic study of Parkinson's disease.

Authors:  M Martinez; A Brice; J R Vaughan; A Zimprich; M M B Breteler; G Meco; A Filla; M J Farrer; C Bétard; J Hardy; G De Michele; V Bonifati; B Oostra; T Gasser; N W Wood; A Dürr
Journal:  J Med Genet       Date:  2004-12       Impact factor: 6.318

6.  Intracellular metal binding and redox behavior of human DJ-1.

Authors:  Letizia Barbieri; Enrico Luchinat; Lucia Banci
Journal:  J Biol Inorg Chem       Date:  2017-12-07       Impact factor: 3.358

Review 7.  Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

Review 8.  The genetics of Parkinson's disease.

Authors:  Kah Leong Lim; Valina L Dawson; Ted M Dawson
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

Review 9.  Combination therapies: The next logical Step for the treatment of synucleinopathies?

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Mov Disord       Date:  2015-09-21       Impact factor: 10.338

10.  Nonsynonymous polymorphisms of histamine-metabolising enzymes in patients with Parkinson's disease.

Authors:  José A G Agúndez; Antonio Luengo; Oscar Herráez; Carmen Martínez; Hortensia Alonso-Navarro; Félix Javier Jiménez-Jiménez; Elena García-Martín
Journal:  Neuromolecular Med       Date:  2007-11-06       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.